4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-028861
Chief Scientific Officer gave up 1,480 shares (to pay taxes)
- Chief Scientific Officer acquired 5,200 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shanler Stuart Chief Scientific Officer | 2018-05-07 | Option exercise | +5,200 | 268,992 | D | ||
| Shanler Stuart Chief Scientific Officer | 2018-05-07 | Shares withheld for taxes | −1,480 | $18.10 | $26,788 | 267,512 | D |
| Derivatives | |||||||
| Shanler Stuart Chief Scientific Officer | 2018-05-07 | Option exercise · Restricted Stock Units | −5,200 | 3,900 | D | ||
Loading xslF345X03/doc4.xml…